The Intuitive Surgical Inc. (ISRG) Set to Announce Earnings on Tuesday

The Intuitive Surgical Inc. (ISRG) Set to Announce Earnings on Tuesday

Intuitive Surgical Inc. (NASDAQ:ISRG) will be releasing its earnings data on Tuesday, October 18th. Persons that are interested in registering for the company’s earnings conference call can do so using this link.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Tuesday, July 19th. The company reported $5.62 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $4.97 by $0.65. Intuitive Surgical had a return on equity of 15.25% and a net margin of 26.80%. The firm earned $670 million during the quarter, compared to analyst estimates of $640.69 million. During the same period in the previous year, the company earned $4.57 EPS. On average, analysts expect Intuitive Surgical to post $21.30 EPS for the current fiscal year and $24.20 EPS for the next fiscal year.

Shares of Intuitive Surgical Inc. (NASDAQ:ISRG) opened at 713.44 on Friday. The company has a 50-day moving average price of $700.61 and a 200 day moving average price of $662.91. The firm has a market capitalization of $27.46 billion, a price-to-earnings ratio of 40.49 and a beta of 0.72. Intuitive Surgical Inc. has a 12-month low of $461.05 and a 12-month high of $727.25.

In other news, CEO Gary S. Guthart sold 13,400 shares of Intuitive Surgical stock in a transaction that occurred on Monday, August 1st. The shares were sold at an average price of $698.00, for a total transaction of $9,353,200.00. Following the completion of the transaction, the chief executive officer now directly owns 78,780 shares in the company, valued at $54,988,440. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Alan J. Levy sold 3,188 shares of Intuitive Surgical stock in a transaction that occurred on Thursday, August 4th. The shares were sold at an average price of $694.11, for a total transaction of $2,212,822.68. Following the transaction, the director now owns 5,401 shares of the company’s stock, valued at $3,748,888.11. The disclosure for this sale can be found here. Insiders own 3.10% of the company’s stock.

Institutional investors have recently added to or reduced their stakes in the stock. Sei Investments Co. raised its position in shares of Intuitive Surgical by 34.7% in the second quarter. Sei Investments Co. now owns 27,475 shares of the company’s stock worth $18,172,000 after buying an additional 7,083 shares during the last quarter. Public Sector Pension Investment Board raised its position in shares of Intuitive Surgical by 18.1% in the second quarter. Public Sector Pension Investment Board now owns 7,171 shares of the company’s stock worth $4,743,000 after buying an additional 1,100 shares during the last quarter. AXA raised its position in shares of Intuitive Surgical by 18.5% in the second quarter. AXA now owns 33,400 shares of the company’s stock worth $22,092,000 after buying an additional 5,214 shares during the last quarter. Trexquant Investment LP purchased a new position in shares of Intuitive Surgical during the second quarter worth $860,000. Finally, Advantus Capital Management Inc raised its position in shares of Intuitive Surgical by 2.4% in the second quarter. Advantus Capital Management Inc now owns 3,798 shares of the company’s stock worth $2,512,000 after buying an additional 90 shares during the last quarter. Hedge funds and other institutional investors own 91.90% of the company’s stock.

Several brokerages have issued reports on ISRG. Piper Jaffray Cos. restated a “neutral” rating and issued a $700.00 price target (up from $610.00) on shares of Intuitive Surgical in a report on Wednesday, July 20th. Barclays PLC increased their price target on Intuitive Surgical from $690.00 to $750.00 and gave the stock an “overweight” rating in a report on Wednesday, July 20th. Zacks Investment Research downgraded Intuitive Surgical from a “hold” rating to a “sell” rating in a report on Monday, June 27th. Canaccord Genuity increased their price target on Intuitive Surgical from $700.00 to $750.00 and gave the stock a “buy” rating in a report on Wednesday, July 20th. Finally, Northland Securities downgraded Intuitive Surgical from a “market perform” rating to an “under perform” rating and set a $600.00 price target for the company. in a report on Thursday, July 21st. One research analyst has rated the stock with a sell rating, six have given a hold rating and fourteen have issued a buy rating to the stock. The stock presently has a consensus rating of “Buy” and a consensus target price of $701.42.

About Intuitive Surgical

Related posts

Leave a Comment